Navigation Links
Neurocrine Biosciences Reports Third Quarter 2011 Results
Date:10/31/2011

urocrine undertakes no obligation to update the statements contained in this press release after the date hereof.NEUROCRINE BIOSCIENCES, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data)(unaudited)Three Months Ended
September 30,  

Nine Months Ended
September 30,  2011  

2010  

2011  

2010  Revenues:Sponsored research and development$  2,396

$  5,210

$  8,589

$  6,519Milestones and license fees39,238

9,238

57,714

13,325Total revenues41,634

14,448

66,303

19,844Operating expenses:Research and development7,456

8,227

22,949

23,086General and administrative3,825

3,635

9,790

9,950Cease-use expense(87)

120

89

401Total operating expenses11,194

11,982

32,828

33,437Income (loss) from operations30,440

2,466

33,475

(13,593)Other income:Gain on sale/disposal of assets86

34

184

202Deferred gain on real estate736

715

2,209

2,145Investment income, net102

118

341

732Other income, net18

31

59Total other income942

867

2,765

3,138Net income (loss)$  31,382

$  3,333

$  36,240

$  (10,455)Net income (loss) per common share:Basic$  0.57

$  0.06<
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
2. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2008 Financial Results
4. Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference
5. Webcast Alert: Neurocrine Announces 3Q 08 Financial Results
6. Neurocrine Biosciences Reports Third Quarter 2008 Results
7. Neurocrine Biosciences to Present at the 20th Annual Piper Jaffray Health Care Conference
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results
9. Neurocrine Biosciences to Present at the Cowen and Company 29th Annual Health Care Conference
10. Neurocrine Biosciences to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
11. Neurocrine Announces Work Force Restructuring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 16, 2014 Cancer Immunotherapy ... Adoptive T-cell Therapies is a new market research ... the three principal types of therapeutics that have ... in cancer immunotherapy (which is often called "immuno-oncology") ... and Adoptive cellular immunotherapy. , The regular ...
(Date:9/15/2014)... , Sept. 15, 2014  FlexTech Alliance ... for flexible, printed product demonstrators (demos) and a ... RFP process with pre-proposals due on October 22, ... Funds for proposals ultimately selected are provided by ... a significant cost share by the proposing organization. ...
(Date:9/15/2014)... fast when a patient has sepsis, a life-threatening condition ... blood -- often too fast for antibiotics to help. ... developed by a team at Harvard,s Wyss Institute for ... treat sepsis. , "Even with the best current ... at least 30 percent of the time," said Mike ...
(Date:9/15/2014)... interdisciplinary team of researchers led by Northeastern University ... precise inter-nanotube junctions and a variety of nanocarbon ... facile and easily scalable, which will allow the ... networks for use in applications ranging from electronic ... from cars to sports equipment. , Their findings ...
Breaking Biology Technology:Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5FlexTech Alliance Issues 2015 Request for Proposals in Flexible, Printed Electronics 2Blood-cleansing biospleen device developed for sepsis therapy 2Blood-cleansing biospleen device developed for sepsis therapy 3Blood-cleansing biospleen device developed for sepsis therapy 4Northeastern University Researchers Develop Novel Method for Working with Nanotubes 2
... International,Corporation (Nasdaq: PRXL ), a leading ... as a Vice President and General,Manager in ... brings more than 20 years of experience ... position, Ms. Fisher leads a global,team of ...
... Healing ... of Chronic Wounds, ... company focused on improving patient quality of life, today,announced that ... its KFH Novo medical device, a breakthrough medical,technology that enhances ...
... a.m. ET; 8:00 a.m. PT, VANCOUVER and SAN ... MGIFF), a clinical-stage developer of drugs for infectious,diseases, will ... 13,2008 at 11:00 a.m. ET (8:00 a.m. PT) to ... 31, 2008 and provide an update on,company activities. To ...
Cached Biology Technology:PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team 2PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team 3PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team 4Kingfisher Healthcare Receives European CE Mark for Next Generation Wound Healing Device 2
(Date:9/15/2014)... outbreak in West Africa, which has claimed more than ... understanding of the molecular biology of the virus that ... antiviral drugs to treat or prevent Ebola hemorrhagic fever. ... USA under the leadership of Dr Dan Engel, ... has obtained the crystal structure of a key ...
(Date:9/15/2014)... it,s not what comes to mind when you think ... Doncaster,s 310-million-year-old past, including a fossilised shark egg case, has ... the fossilised plants and creatures may even be new to ... crabs and some previously unrecorded seed pods are amongst the ... within the coal and shale deposits in what is one ...
(Date:9/15/2014)... reports about the need for vitamin E and how ... that adequate levels of this essential micronutrient are especially ... who are or may become pregnant. , A lifelong ... said, but often complicated by the fact that this ... through diet alone. It has been estimated that only ...
Breaking Biology News(10 mins):Protein secrets of Ebola virus 2'Jaws' lived in Doncaster 2Vitamin E intake critical during 'the first 1,000 days' 2Vitamin E intake critical during 'the first 1,000 days' 3
... shrimp. Fried eggs. Burgers and fries. New research suggests ... foods are so appealing together. It has been known ... uptake, but fundamental aspects of that process remain poorly understood. ... for Science are using zebrafish to better understand the cellular ...
... People with celiac disease struggle with limited food choices, ... in wheat and other grains. Researchers from the University ... banana flour, which tasters found more acceptable than regular whole ... cheaper to produce than standard pastas. Their research is ...
... first paternity study of southern right whales has found a ... say, which is good news for the overall genetic diversity ... through in-breeding. Results of the study, by researchers at ... Zealand Department of Conservation, have just been published in the ...
Cached Biology News:Zebrafish research shows how dietary fat regulates cholesterol absorption 2Pasta made from green banana flour a tasty alternative for gluten-free diets 2First paternity study of southern right whales finds local fathers most successful 2First paternity study of southern right whales finds local fathers most successful 3
Phospho-TAO2 (S181) Affinity Purified Polyclonal Ab Protein Family: Other Intracellular Kinases...
PEG 8000, Molecular Biology Grade...
... Deacetylase (HDAC) Antibody Sampler Kit Kit ... Catalog #2062, 40 ul Histone Deacetylase 3 ... Deacetylase 4 (HDAC4) Antibody, Catalog #2072, 40 ... #2082, 40 ul Histone Deacetylase 6 (HDAC6) ...
Immunogen: Synthetic Peptide: C N(185) D G T E F G G S I Y Q K(197) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: